HomeCompareNESIX vs JNJ

NESIX vs JNJ: Dividend Comparison 2026

NESIX yields 7.90% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NESIX wins by $13.7K in total portfolio value
10 years
NESIX
NESIX
● Live price
7.90%
Share price
$25.31
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$33.7K
Annual income
$1,303.15
Full NESIX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — NESIX vs JNJ

📍 NESIX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNESIXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NESIX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NESIX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NESIX
Annual income on $10K today (after 15% tax)
$671.67/yr
After 10yr DRIP, annual income (after tax)
$1,107.68/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, NESIX beats the other by $404.06/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NESIX + JNJ for your $10,000?

NESIX: 50%JNJ: 50%
100% JNJ50/50100% NESIX
Portfolio after 10yr
$26.9K
Annual income
$1,065.46/yr
Blended yield
3.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NESIX
No analyst data
Altman Z
1.0
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NESIX buys
0
JNJ buys
0
No recent congressional trades found for NESIX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNESIXJNJ
Forward yield7.90%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$33.7K$20.0K
Annual income after 10y$1,303.15$827.78
Total dividends collected$10.5K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NESIX vs JNJ ($10,000, DRIP)

YearNESIX PortfolioNESIX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,490$790.20$10,676$355.77+$814.00NESIX
2$13,143$848.56$11,407$389.39+$1.7KNESIX
3$14,970$907.13$12,198$426.53+$2.8KNESIX
4$16,984$965.64$13,056$467.62+$3.9KNESIX
5$19,196$1,023.85$13,987$513.12+$5.2KNESIX
6$21,622$1,081.54$14,998$563.56+$6.6KNESIX
7$24,274$1,138.48$16,098$619.52+$8.2KNESIX
8$27,167$1,194.51$17,295$681.69+$9.9KNESIX
9$30,319$1,249.44$18,599$750.82+$11.7KNESIX
10$33,744$1,303.15$20,022$827.78+$13.7KNESIX

NESIX vs JNJ: Complete Analysis 2026

NESIXStock

Under normal conditions, the fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the equity securities (principally, common stock) of domestic issuers listed on a nationally recognized securities exchange that have market capitalizations not exceeding $8 billion.

Full NESIX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this NESIX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NESIX vs SCHDNESIX vs JEPINESIX vs ONESIX vs KONESIX vs MAINNESIX vs ABBVNESIX vs MRKNESIX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.